Melissa Alsina

6PUBLICATIONS
106CO-AUTHORS
Cancer diagnosisCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markersGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jun 03, 2026
Integrated Genomic and Epigenomic Analysis Reveals Epigenetic Plasticity in Disease Progression and Multidrug Resistance in Multiple Myeloma.

|Jan 21, 2026
Anti-B-cell Maturation Antigen Chimeric Antigen Receptor T-cell Therapy bb21217 for Relapsed and Refractory Multiple Myeloma: Results from the Phase I CRB-402 Study.

Melissa Alsina, Nina Shah, Sundar Jagannath

|Mar 18, 2025
Establishing a successful outpatient CAR T-Cell program with cilta-cel: real-world experience from an expert roundtable.

Melissa Alsina, Binod Dhakal, Jeremy Pantin

|Feb 18, 2025
Comparison of Standard-of-Care Idecabtagene Vicleucel and Ciltacabtagene Autoleucel in Relapsed/Refractory Multiple Myeloma.

Doris K Hansen, Lauren C Peres, Danai Dima

|Oct 30, 2024
The Functional Transcriptomic Landscape Informs Therapeutic Strategies in Multiple Myeloma.

Praneeth Reddy Sudalagunta, Rafael R Canevarolo, Mark B Meads

|Sep 22, 2023
Survivin Dendritic Cell Vaccine Safely Induces Immune Responses and Is Associated with Durable Disease Control after Autologous Transplant in Patients with Myeloma.

Ciara L Freeman, Reginald Atkins, Indumathy Varadarajan

Pageof 1

Frequent Collaborators

3 joint publications

Gabriel DeAvila

3 joint publications

Rachid Baz

3 joint publications

Jason Brayer

3 joint publications

Bijal Shah